Skip to search formSkip to main contentSkip to account menu

pyrazolopyridine

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

PyrazolesPyridines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Synthesis of Some Novel Pyridazine , Thienopyridazine , Pyrazolopyridine , Pyridopyrazolopyrimidine and Pyridopyrazolotriazine Derivatives with Their Antimicrobial Activity
Coupling of compound 1 with diazotized aromatic amines in ethanol afforded the arylhydrazones 3a,b. Fusion of 3a,b with active… 
2012
2012
SYNTHESIS AND PHARMACOLOGICAL SCREENING OF PYRAZOLOPYRIDINE COMPOUNDS AS ANXIOLYTICS
Amine & chloro derivatives of Ethyl 4 b)pyridine-5-carboxylate & carboxylic acid were synthesized usin g liquid ammonia… 
2010
2010
Antiplatelet activity and structure-activity relationship study of Pyrazolopyridine Derivatives as potential series for treating thrombotic diseases.
AIM Platelets plays a central role in hemostatic processes and consequently are similarly involved in pathological processes… 
2009
2009
Pyrazolopyridine derivatives as nadph-oxidase inhibitors
FIELD: medicine, pharmaceutics. SUBSTANCE: invention refers to pyrazolopyridine derivatives of formula (I) , a based… 
2009
2009
Pyrazolopyridine derivatives as NADPH oxidase inhibitors
The present invention relates to pyrazolopiperidine derivatives of formula (I), pharmaceutical compositions thereof, and these… 
Highly Cited
2008
Highly Cited
2008
Potent, selective, orally bioavailable inhibitors of tumor necrosis factor-alpha converting enzyme (TACE): discovery of indole, benzofuran, imidazopyridine and pyrazolopyridine P1' substituents.
2005
2005
Potent, orally active corticotropin-releasing factor receptor-1 antagonists containing a tricyclic pyrrolopyridine or pyrazolopyridine core.
Two new classes of tricyclic-based corticotropin-releasing factor (CRF(1)) receptor-1 antagonists were designed by constraining… 
2004
2004
New orally active PDE4 inhibitors with therapeutic potential.
1994
1994
Pyrazolopyridine Derivative Acts as a Novel Cyclooxygenase Inhibitor: Antiplatelet Effect in Aged Patients with Ischemic Stroke
Objective: To examine the antiplatelet effect of a novel pyrazolopyridine derivative (KC‐764) in geriatric patients with ischemic… 
1988
1988
CNS depressants accelerate the dissociation of 35S-TBPS binding and GABA enhances their displacing potencies.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)